Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

4A7G

Structure of human I113T SOD1 mutant complexed with 4-methylpiperazin- 1-yl)quinazoline in the p21 space group.

Summary for 4A7G
Entry DOI10.2210/pdb4a7g/pdb
Related1AZV 1BA9 1DSW 1FUN 1HL4 1HL5 1KMG 1L3N 1MFM 1N18 1N19 1OEZ 1OZT 1OZU 1P1V 1PTZ 1PU0 1RK7 1SOS 1SPD 1UXL 1UXM 2AF2 2C9S 2C9U 2C9V 2V0A 2VR6 2VR7 2VR8 2WKO 2WYT 2WYZ 2WZ0 2WZ5 2WZ6 2XJK 2XJL 4SOD
DescriptorSUPEROXIDE DISMUTASE [CU-ZN], SULFATE ION, 4-(4-METHYLPIPERAZIN-1-YL)QUINAZOLINE, ... (8 entities in total)
Functional Keywordsoxidoreductase, amyotrophic lateral sclerosis, antioxidant, disease mutation, metal-binding, zn superoxide dismutase
Biological sourceHOMO SAPIENS (HUMAN)
More
Total number of polymer chains2
Total formula weight33101.11
Authors
Wright, G.S.A.,Kershaw, N.M.,Sharma, R.,Antonyuk, S.V.,Strange, R.W.,Berry, N.G.,O'Neil, P.M.,Hasnain, S.S. (deposition date: 2011-11-14, release date: 2012-10-24, Last modification date: 2024-10-16)
Primary citationKershaw, N.M.,Wright, G.S.,Sharma, R.,Antonyuk, S.V.,Strange, R.W.,Berry, N.G.,O'Neill, P.M.,Hasnain, S.S.
X-ray crystallography and computational docking for the detection and development of protein-ligand interactions.
Curr.Med.Chem., 20:569-575, 2013
Cited by
PubMed Abstract: Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterised by the selective dysfunction and death of the upper and lower motor neurons. Median survival rates are between 3 and 5 years after diagnosis. Mutations in the gene encoding Cu/Zn superoxide dismutase (SOD1) have been linked to a subset of familial forms of ALS (fALS). Herein, we describe a fragment- based drug discovery (FBDD) approach for the investigation of small molecule binding sites in SOD1. X-ray crystallography has been used as the primary screening method and has been shown to directly detect protein-ligand interactions which cannot be unambiguously identified using other biophysical methods. The structural requirements for effective binding at Trp32 are detailed for a series of quinazoline-containing compounds. The investigation of an additional site that binds a range of catecholamines and the use of computational modelling to assist fragment evolution is discussed. This study also highlights the importance of ligand solubility for successful Xray crystallographic campaigns in lead compound design.
PubMed: 23278398
DOI: 10.2174/0929867311320040008
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (1.24 Å)
Structure validation

229183

PDB entries from 2024-12-18

PDB statisticsPDBj update infoContact PDBjnumon